Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

Objective: To review the reimbursement recommendations issued by selected European health technology assessment agencies for orphan drugs and the reimbursement status of these drugs; to assess the relationship between the type of recommendation and reimbursement status.Methods: The list of orphan dr...

Full description

Bibliographic Details
Main Authors: Ewa Stawowczyk, Krzysztof Piotr Malinowski, Paweł Kawalec, Rafał Bobiński, Jacek Siwiec, Dimitra Panteli, Helene Eckhardt, Steven Simoens, Antònia Agusti, Marc Dooms, Andrzej Pilc
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Pharmacology
Subjects:
health technology assessment
drug policy
rare disease
reimbursement
orphan
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01279/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01279/full

Similar Items